Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,241,600 | 3,232,000 | 2,107,000 | 957,500 | 1,217,400 |
| Depreciation Amortization | 356,500 | 1,609,000 | 1,263,500 | 848,000 | 422,800 |
| Income taxes - deferred | -72,400 | 326,800 | 161,600 | 134,800 | -22,700 |
| Accounts receivable | N/A | -996,700 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | -284,500 | N/A | N/A | N/A |
| Other Working Capital | -714,300 | -2,378,700 | -1,638,200 | -1,749,000 | -1,270,000 |
| Other Operating Activity | -3,500,100 | 4,016,600 | 2,181,900 | 1,762,700 | 89,000 |
| Operating Cash Flow | $311,300 | $5,524,500 | $4,075,800 | $1,954,000 | $436,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,200 | 2,440,300 | 2,423,300 | 2,384,500 | 338,500 |
| PPE Investments | -203,700 | -1,210,600 | -816,300 | -546,500 | -236,500 |
| Net Acquisitions | -6,917,700 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -60,600 | -837,900 | -719,700 | -676,500 | -561,600 |
| Sale Of Investment | 83,600 | 3,509,500 | 3,444,700 | 3,395,100 | 310,500 |
| Other Investing Activity | -582,500 | -1,995,300 | -1,767,000 | -1,593,500 | -21,200 |
| Investing Cash Flow | $-7,678,700 | $1,906,000 | $2,565,000 | $2,963,100 | $-170,300 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,850,400 | -2,197,900 | -2,297,100 | -248,700 | -1,202,500 |
| Debt Issued | 4,448,300 | 2,477,700 | 2,477,700 | N/A | N/A |
| Debt Repayment | -600,000 | -1,009,100 | -1,001,500 | -1,001,500 | -800,300 |
| Common Stock Issued | N/A | 1,659,700 | 1,659,700 | N/A | N/A |
| Common Stock Repurchased | -3,500,000 | -4,150,700 | -3,050,700 | -2,050,700 | -1,100,000 |
| Dividend Paid | -637,200 | -2,311,800 | -1,739,200 | -1,166,600 | -587,300 |
| Other Financing Activity | -193,700 | -372,800 | -314,100 | -230,400 | -176,400 |
| Financing Cash Flow | $1,367,800 | $-5,904,900 | $-4,265,200 | $-4,697,900 | $-3,866,500 |
| Exchange Rate Effect | 37,800 | -63,600 | 48,200 | 61,900 | 148,400 |
| Beginning Cash Position | 7,998,200 | 6,536,200 | 6,536,200 | 6,536,200 | 6,536,200 |
| End Cash Position | 2,036,400 | 7,998,200 | 8,960,000 | 6,817,300 | 3,084,300 |
| Net Cash Flow | $-5,961,800 | $1,462,000 | $2,423,800 | $281,100 | $-3,451,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 311,300 | 5,524,500 | 4,075,800 | 1,954,000 | 436,500 |
| Capital Expenditure | -203,700 | -1,210,600 | -816,300 | -546,500 | -236,500 |
| Free Cash Flow | 107,600 | 4,313,900 | 3,259,500 | 1,407,500 | 200,000 |